Literature DB >> 12427891

Mitochondrial disorders: a proposal for consensus diagnostic criteria in infants and children.

Nicole I Wolf1, Jan A M Smeitink.   

Abstract

BACKGROUND: In 1996 diagnostic criteria were published for adults with respiratory chain disorders. Modified criteria for children were also recently proposed.
OBJECTIVE: To facilitate and standardize diagnosis of respiratory chain disorders in children.
METHODS: A new classification has been developed, the Mitochondrial Disease Criteria (MDC), for the diagnosis of respiratory chain disorders in infants and children. It considers clinical, metabolic, imaging, and histopathologic features vs biochemical investigations of skeletal muscle. The criteria were applied to a group of 30 children.
RESULTS: The modified adult criteria and the MDC gave similar results, with 17 patients having a definite respiratory chain disorder. No patients reached this category using the original adult criteria.
CONCLUSIONS: The proposed Mitochondrial Disease Criteria classification allows more precise definition of clinical and metabolic items and the independent scoring of muscle biochemical investigations before combining all findings to determine the overall diagnostic certainty.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12427891     DOI: 10.1212/01.wnl.0000031795.91814.d8

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  56 in total

1.  Possible mitochondrial dysfunction and its association with antiretroviral therapy use in children perinatally infected with HIV.

Authors:  Marilyn J Crain; Miriam C Chernoff; James M Oleske; Susan B Brogly; Kathleen M Malee; Peggy R Borum; William A Meyer; Wendy G Mitchell; John H Moye; Heather M Ford-Chatterton; Russell B Van Dyke; George R Seage Iii
Journal:  J Infect Dis       Date:  2010-07-15       Impact factor: 5.226

2.  The Use of the Medical Dictionary for Regulatory Activities in the Identification of Mitochondrial Dysfunction in HIV-Infected Children.

Authors:  Miriam Chernoff; Heather Ford-Chatterton; Marilyn J Crain
Journal:  Case Studies Bus Ind Gov Stat       Date:  2012-10

3.  Design and implementation of the first randomized controlled trial of coenzyme CoQ₁₀ in children with primary mitochondrial diseases.

Authors:  Peter W Stacpoole; Ton J deGrauw; Annette S Feigenbaum; Charles Hoppel; Douglas S Kerr; Shawn E McCandless; Michael V Miles; Brian H Robinson; Peter H Tang
Journal:  Mitochondrion       Date:  2012-09-25       Impact factor: 4.160

Review 4.  Neuromuscular and systemic presentations in adults: diagnoses beyond MERRF and MELAS.

Authors:  Bruce H Cohen
Journal:  Neurotherapeutics       Date:  2013-04       Impact factor: 7.620

Review 5.  Primary Mitochondrial Disease and Secondary Mitochondrial Dysfunction: Importance of Distinction for Diagnosis and Treatment.

Authors:  Dmitriy M Niyazov; Stephan G Kahler; Richard E Frye
Journal:  Mol Syndromol       Date:  2016-06-03

6.  Nonspecific mitochondrial disease with epilepsy in children: diagnostic approaches and epileptic phenotypes.

Authors:  Hoon-Chul Kang; Ji Won Kwon; Young Mock Lee; Heung Dong Kim; Hong Jin Lee; Si Houn Hahn
Journal:  Childs Nerv Syst       Date:  2007-06-19       Impact factor: 1.475

7.  Mitochondrial Respiratory Disorders: A Perspective on their Metabolite Biomarkers and Implications for Clinical Diagnosis and Therapeutic Intervention.

Authors:  Martine Uittenbogaard; Anne Chiaramello
Journal:  Biomark J       Date:  2015-10-12

8.  Neuroradiologic findings in children with mitochondrial disorder: correlation with mitochondrial respiratory chain defects.

Authors:  Jinna Kim; Seung-Koo Lee; Eung Yeop Kim; Dong Ik Kim; Young-Mock Lee; Joon Soo Lee; Heung Dong Kim
Journal:  Eur Radiol       Date:  2008-04-04       Impact factor: 5.315

Review 9.  Biochemical diagnosis of mitochondrial disorders.

Authors:  Richard J T Rodenburg
Journal:  J Inherit Metab Dis       Date:  2010-05-04       Impact factor: 4.982

Review 10.  Mitochondrial disorders.

Authors:  Massimo Zeviani; Antonella Spinazzola
Journal:  Curr Neurol Neurosci Rep       Date:  2003-09       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.